How do you counsel NCCN low and very low risk prostate cancer patients who receive a high risk DECIPHER score?

I do not order Decipher in NCCN low or very low risk. I'm not sure very low risk is even a relevant category in modern practice. The 15-year results from ProtecT demonstrate excellent outcomes for those on the active monitoring arm. Critically, those patients were mostly diagnosed in the pre-MRI era...